Prevalence of polymorphisms in DHFR, DHPS, PFMDR1 and PFCRT genes of Plasmodium falciparum isolates in Quang Tri Province, Vietnam
In 2002 an antimalarial drug resistance survey was carried out in a seasonally endemic area of Vietnam. Sulfadoxine/pyrimethamine (S/P) was the standard treatment recommended for uncomplicated Plasmodium falciparum malaria in that area at the time. Early or late treatment failure as defined by WHO was observed in 14.9% (7/47) of patients. Molecular analysis of treatment failure isolates identified that 5/6 carried two or more dhfr and dhps polymorphisms associated with S/P resistance. Chloroquine resistance-associated polymorphisms occurred in 38.5% (15/39) of the isolates. These results support the move to artemisinin-based combination therapy for malaria in Vietnam.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
---|---|
Enthalten in: |
The Southeast Asian journal of tropical medicine and public health - 39(2008), 6 vom: 01. Nov., Seite 959-62 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Phuc, Bui Q [VerfasserIn] |
---|
Themen: |
37338-39-9 |
---|
Anmerkungen: |
Date Completed 17.02.2009 Date Revised 21.11.2013 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM18499408X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM18499408X | ||
003 | DE-627 | ||
005 | 20231223171627.0 | ||
007 | tu | ||
008 | 231223s2008 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0617.xml |
035 | |a (DE-627)NLM18499408X | ||
035 | |a (NLM)19062682 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Phuc, Bui Q |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevalence of polymorphisms in DHFR, DHPS, PFMDR1 and PFCRT genes of Plasmodium falciparum isolates in Quang Tri Province, Vietnam |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 17.02.2009 | ||
500 | |a Date Revised 21.11.2013 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a In 2002 an antimalarial drug resistance survey was carried out in a seasonally endemic area of Vietnam. Sulfadoxine/pyrimethamine (S/P) was the standard treatment recommended for uncomplicated Plasmodium falciparum malaria in that area at the time. Early or late treatment failure as defined by WHO was observed in 14.9% (7/47) of patients. Molecular analysis of treatment failure isolates identified that 5/6 carried two or more dhfr and dhps polymorphisms associated with S/P resistance. Chloroquine resistance-associated polymorphisms occurred in 38.5% (15/39) of the isolates. These results support the move to artemisinin-based combination therapy for malaria in Vietnam | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Antimalarials |2 NLM | |
650 | 7 | |a DNA, Protozoan |2 NLM | |
650 | 7 | |a Drug Combinations |2 NLM | |
650 | 7 | |a Protozoan Proteins |2 NLM | |
650 | 7 | |a fanasil, pyrimethamine drug combination |2 NLM | |
650 | 7 | |a 37338-39-9 |2 NLM | |
650 | 7 | |a Sulfadoxine |2 NLM | |
650 | 7 | |a 88463U4SM5 |2 NLM | |
650 | 7 | |a Chloroquine |2 NLM | |
650 | 7 | |a 886U3H6UFF |2 NLM | |
650 | 7 | |a Pyrimethamine |2 NLM | |
650 | 7 | |a Z3614QOX8W |2 NLM | |
700 | 1 | |a Caruana, Sonia R |e verfasserin |4 aut | |
700 | 1 | |a Cowman, Alan F |e verfasserin |4 aut | |
700 | 1 | |a Biggs, Beverley-Ann |e verfasserin |4 aut | |
700 | 1 | |a Thanh, Ngo V |e verfasserin |4 aut | |
700 | 1 | |a Tien, Nong T |e verfasserin |4 aut | |
700 | 1 | |a Thuan, Le K |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Southeast Asian journal of tropical medicine and public health |d 1971 |g 39(2008), 6 vom: 01. Nov., Seite 959-62 |w (DE-627)NLM000044679 |x 0125-1562 |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:2008 |g number:6 |g day:01 |g month:11 |g pages:959-62 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 39 |j 2008 |e 6 |b 01 |c 11 |h 959-62 |